Advertisement

Ozempic

GLP-1 Drugs Trigger Multi-Billion Dollar Demand Shock in Food Sector

Sylvain Charlebois -
GLP-1 drugs are shifting Canadians from volume to value in food consumption, with major implications for retailers and restaurants.

GLP-1 Drugs Disrupt Eating Habits, Hit Fast Food

Sylvain Charlebois -
Appetite-suppressing GLP-1 drugs like Ozempic are reshaping consumer behaviour, posing a major challenge to fast-food chains like McDonald’s.

GLP-1 Drugs Could Reshape Canada’s Food Industry

Sylvain Charlebois -
Canada's new obesity guidelines signal a shift in food consumption, with GLP-1 drugs impacting how and what Canadians—especially youth—eat.

How Ozempic’s Soaring Demand for Weight Loss could Impact Canada’s Food Industry [Op-Ed]

Sylvain Charlebois -
Sylvain Charlebois says that the surging demand for weight-control drugs is also causing a noticeable shift in the food industry as consumers buy fewer groceries.
- Advertisement -
spot_img
spot_img

About

Contact

Media

Follow

© 2025 Retail Insider Media Ltd. All Rights Reserved. The content on this website is protected by the copyrights of Retail Insider Media Ltd. or the copyrights of third parties and used by agreement. No part of any of the content of this website may be reproduced, distributed, modified, framed, cached, adapted or linked to, or made available in any form by any photographic, electronic, digital, mechanical, photostat, microfilm, xerography or other means, or incorporated into or used in any information storage and retrieval system, electronic or mechanical, without the prior written permission of Retail Insider Media Ltd. or the applicable third party copyright owner.